Finance

Lists
000250:KOSDAQ
Sam Chun Dang Pharm Co Ltd
â‚©165,100.00
+1.35%
(+2,200.00) 1D
Sep 9, 3:30:14 PM GMT+9  ·   KRW
All symbols
SymbolPriceChange% Change
Generating top insights for 000250...
Open
â‚©161,500
High
â‚©166,100
Low
â‚©161,000
Mkt. cap
3.87T
Avg. vol.
163.83K
Volume
59.57K
Dividend
0.03%
Quarterly dividend
â‚©13
Ex-dividend date
Dec 29, 2025
P/E ratio
216.58
52-wk high
â‚©1,233,000
52-wk low
â‚©120,000
EPS
â‚©762
Shares outstanding
23.46M
No. of employees
423
Open
â‚©161,500
High
â‚©166,100
Low
â‚©161,000
Mkt. cap
3.87T
Avg. vol.
163.83K
Volume
59.57K
Dividend
0.03%
Quarterly dividend
â‚©13
Ex-dividend date
Dec 29, 2025
P/E ratio
216.58
52-wk high
â‚©1,233,000
52-wk low
â‚©120,000
EPS
â‚©762
Shares outstanding
23.46M
No. of employees
423
About Sam Chun Dang Pharm Co Ltd
CEO-
Employees423
Founded1943
Headquarters-
SectorPharmaceutical industry
Website-
Previous reportsAll values in KRW
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in KRW
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
58.02B
66.26B
64.87B
70.74B
Cost of goods sold
30.97B
34.78B
33.09B
38.33B
Cost of revenue
30.97B
34.78B
33.09B
38.33B
Research and development expenses
1.01B
1.73B
1.64B
2.65B
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
21.94B
22.60B
23.18B
24.75B
Operating expense
23.62B
26.10B
26.33B
28.97B
Total operating expenses
54.59B
60.88B
59.42B
67.31B
Operating income
3.43B
5.38B
5.45B
3.44B
Other non operating income
-24.66M
439.40M
34.98M
-27.15M
EBT including unusual items
5.25B
7.43B
8.43B
8.56B
EBT excluding unusual items
4.71B
7.33B
7.23B
5.31B
Income tax expense
789.23M
-474.71M
1.53B
2.36B
Effective tax rate
15.03%
-6.39%
18.12%
27.53%
Other operating expenses
387.28M
397.92M
323.16M
298.36M
Net income
2.57B
5.55B
5.45B
4.21B
Net profit margin
4.43%
8.37%
8.40%
5.96%
Earnings per share
-
-
-
-
Interest and investment income
722.65M
761.78M
612.21M
764.31M
Interest expense
-589.76M
-61.72M
-491.90M
318.65M
Net interest expenses
132.89M
700.06M
120.30M
1.08B
Depreciation and amortization charges
707.10M
709.38M
718.63M
702.07M
EBITDA
5.68B
8.58B
8.64B
6.64B
Gain or loss from assets sale
37.77M
-440.92M
-35.54M
108.59K
AI content may include mistakes. Learn more
Google apps